YJ1206

YJ1206 is a modulator of CDK used in studies of DNA Damage Response and Cell Cycle Regulation and related signaling programs. It is especially relevant in apoptosis, cancer, and cell cycle models, where defined compound exposure can be linked to checkpoint activation, DNA repair, and genome-stability control and checkpoint control, mitotic progression, and proliferation timing.

By modulating CDK, YJ1206 can be used to examine checkpoint activation, DNA repair, and genome-stability control and checkpoint control, mitotic progression, and proliferation timing. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving CDK
• Pathway perturbation studies connected to DNA Damage Response and Cell Cycle Regulation and related signaling programs
• Context-dependent response profiling and mechanism comparison
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, YJ1206 is appropriate when a defined chemical perturbant is needed to connect CDK with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.